EIDX - Eidos Therapeutics - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

with an average price target of $9.86. This is a potential upside of $9.86 (0%) from yesterday's end of day stock price of $0.

Eidos Therapeutics's activity chart (see below) currently has 5 price targets and 4 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 91.67 days.

Most recent stock forecast was given by JOEL BEATTY from BAIRD on 29-Dec-2020. First documented stock forecast 27-Aug-2018.

Best performing analysts who are covering EIDX - Eidos Therapeutics:

Tyler Van Buren Joel Beatty Anupam Rama

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

129

$6.79 (5.56%)

73

3 years 3 months 27 days ago

3/3 (100%)

$12.92 (27.92%)

26

Hold

73.26

$-48.95 (-40.05%)

80

3 years 6 months 20 days ago

3/3 (100%)

$-0.25 (-0.34%)

128

Hold

3 years 11 months 11 days ago

1/1 (100%)

$16.9 (139.67%)

121

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is EIDX (Eidos Therapeutics) average time for price targets to be met?

On average it took 91.67 days on average for the stock forecasts to be realized with a an average price target met ratio 100

Which analyst has the current highest performing score on EIDX (Eidos Therapeutics) with a proven track record?

TYLER VAN BUREN

Which analyst has the current lower performing score on EIDX (Eidos Therapeutics) with a proven track record?

ANUPAM RAMA

Which analyst has the most public recommendations on EIDX (Eidos Therapeutics)?

Tyler Van Buren works at TD COWEN and has 5 price targets and 3 ratings on EIDX

Which analyst is the currently most bullish on EIDX (Eidos Therapeutics)?

Joel Beatty with highest potential upside - $6.79

Which analyst is the currently most reserved on EIDX (Eidos Therapeutics)?

Tyler Van Buren with lowest potential downside - -$48.95

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?